Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Statistics

Total Valuation

Ajooni Biotech has a market cap or net worth of INR 663.14 million. The enterprise value is 598.98 million.

Market Cap	663.14M
Enterprise Value	598.98M

Important Dates

The next estimated earnings date is Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Ajooni Biotech has 172.24 million shares outstanding. The number of shares has decreased by -67.93% in one year.

Current Share Class	172.24M
Shares Outstanding	172.24M
Shares Change (YoY)	-67.93%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	17.59%
Owned by Institutions (%)	n/a
Float	129.84M

Valuation Ratios

The trailing PE ratio is 5.45.

PE Ratio	5.45
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.74
P/TBV Ratio	0.74
P/FCF Ratio	11.81
P/OCF Ratio	3.54
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.66, with an EV/FCF ratio of 10.66.

EV / Earnings	14.97
EV / Sales	0.47
EV / EBITDA	9.66
EV / EBIT	12.38
EV / FCF	10.66

Financial Position

The company has a current ratio of 14.30, with a Debt / Equity ratio of 0.10.

Current Ratio	14.30
Quick Ratio	5.95
Debt / Equity	0.10
Debt / EBITDA	1.43
Debt / FCF	1.58
Interest Coverage	101.88

Financial Efficiency

Return on equity (ROE) is 4.55% and return on invested capital (ROIC) is 4.63%.

Return on Equity (ROE)	4.55%
Return on Assets (ROA)	3.13%
Return on Invested Capital (ROIC)	4.63%
Return on Capital Employed (ROCE)	4.89%
Weighted Average Cost of Capital (WACC)	5.73%
Revenue Per Employee	9.55M
Profits Per Employee	298,672
Employee Count	134
Asset Turnover	1.32
Inventory Turnover	5.10

Taxes

In the past 12 months, Ajooni Biotech has paid 11.67 million in taxes.

Income Tax	11.67M
Effective Tax Rate	22.58%

Stock Price Statistics

The stock price has decreased by -49.74% in the last 52 weeks. The beta is 0.40, so Ajooni Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-49.74%
50-Day Moving Average	4.42
200-Day Moving Average	5.27
Relative Strength Index (RSI)	32.12
Average Volume (20 Days)	270,765

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ajooni Biotech had revenue of INR 1.28 billion and earned 40.02 million in profits. Earnings per share was 0.71.

Revenue	1.28B
Gross Profit	253.48M
Operating Income	48.39M
Pretax Income	51.69M
Net Income	40.02M
EBITDA	62.01M
EBIT	48.39M
Earnings Per Share (EPS)	0.71

Balance Sheet

The company has 152.87 million in cash and 88.71 million in debt, with a net cash position of 64.16 million or 0.37 per share.

Cash & Cash Equivalents	152.87M
Total Debt	88.71M
Net Cash	64.16M
Net Cash Per Share	0.37
Equity (Book Value)	897.92M
Book Value Per Share	7.71
Working Capital	695.43M

Cash Flow

In the last 12 months, operating cash flow was 187.20 million and capital expenditures -131.03 million, giving a free cash flow of 56.17 million.

Operating Cash Flow	187.20M
Capital Expenditures	-131.03M
Free Cash Flow	56.17M
FCF Per Share	0.33

Margins

Gross margin is 19.81%, with operating and profit margins of 3.78% and 3.13%.

Gross Margin	19.81%
Operating Margin	3.78%
Pretax Margin	4.04%
Profit Margin	3.13%
EBITDA Margin	4.85%
EBIT Margin	3.78%
FCF Margin	4.39%

Dividends & Yields

Ajooni Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	67.93%
Shareholder Yield	67.93%
Earnings Yield	6.04%
FCF Yield	8.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 7, 2022. It was a forward split with a ratio of 5.

Last Split Date	Oct 7, 2022
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	6